F3 Logic, LLC Pfizer Inc Transaction History

F3 Logic, LLC

$475 Million
Q4 2022

A detailed history of F3 Logic, LLC transactions in Pfizer Inc stock. As of the latest transaction made, F3 Logic, LLC holds 18,818 shares of PFE stock, worth $469,320. This represents 0.2% of its overall portfolio holdings.

Number of Shares

18,818

Previous 21,377 11.97%

Holding current value

$469,320

Previous $942,000 2.34%

% of portfolio

0.2%

Previous 0.2%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $106,838 - $139,465	-2,559 Reduced 11.97%	18,818 $964,000
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $690,270 - $842,647	-15,774 Reduced 42.46%	21,377 $942,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $1.49 Million - $1.77 Million	32,030 Added 625.46%	37,151 $1.11 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $34,678 - $42,971	-758 Reduced 12.89%	5,121 $266,000
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $39,254 - $58,187	-950 Reduced 13.91%	5,879 $349,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $60,013 - $77,092	1,529 Added 28.85%	6,829 $297,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $190,322 - $215,604	5,300 New	5,300 $208,000
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $510,710 - $662,241	-15,719 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $44,191 - $49,616	-1,195 Reduced 7.07%	15,719 $678,000
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $256,387 - $281,684	6,837 Added 67.85%	16,914 $717,000
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $387,662 - $441,977	10,077 New	10,077 $439,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

News

Stay updated on F3 Logic, LLC with notifications on news.

Account